StockDuty ← Dashboard Oct 28, 2026 08:09 AM ET
SignalCorporate

GSK Non-GAAP EPS of £0.55 beats by £0.04, revenue of £8.89B beats by £50M; reaffirms FY outlook

GSK beat EPS and revenue estimates while reaffirming full-year outlook.

GSK beat EPS and revenue estimates while reaffirming full-year outlook.
GSK beat EPS and revenue estimates while reaffirming full-year outlook. — impact context not separately stored; see What changed.
Sources